Avastin
Third Biosimilar to Bevacizumab Approved
The FDA approved bevacizumab-maly (Alymsys, Amneal Pharmaceuticals), a biosimilar to bevacizumab (Avastin, ...
APRIL 19, 2022
FDA Approves Avastin Plus Chemo for Certain Women With Advanced Ovarian Cancer
The FDA granted a new indication for Avastin in combination with chemotherapy, followed by Avastin as a single ...
JUNE 18, 2018
FDA Gives Full Approval to Avastin for Recurrent GBM
The FDA has granted full approval for bevacizumab (Avastin, Genentech) for the treatment of adults with ...
DECEMBER 7, 2017
Novel Agent Produces Highest OS to Date in PRmCC
National Harbor, Md.—Data from a multicenter trial of a novel targeted immunotherapy for the treatment of ...
JULY 14, 2017
Combination Therapy Shows Promise in mRCC
The combination of atezolizumab (Tecentriq, Genentech) and bevacizumab (Avastin, Genentech) appears to be a ...
JUNE 28, 2017